Neuron23

Developer of an artificial intelligence-based drug discovery model designed for genetically defined neurological and immunological diseases. The company's platform leverages recent advances in human g...

Healthcare

South San Francisco, CA, United States

Founded 2018

54 employees

Website

Valuation

$271.5M

Market implied

Share Price

N/A

Total Raised

$310M

Last Round

N/A

Investors

+14 other investors

View all 14 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Neuron23's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required